CC
VCYT icon

Casdin Capital’s Veracyte VCYT Stock Holding History

Casdin Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.9M Hold
276,308
– – 0.67% 26
2025
Q4 		$11.6M Hold
276,308
– – 0.72% 21
2025
Q3 		$9.49M Hold
276,308
– – 0.79% 19
2025
Q2 		$7.47M Hold
276,308
– – 0.68% 18
2025
Q1 		$8.19M Hold
276,308
– – 0.67% 23
2024
Q4 		$10.9M Sell
276,308
-390,000
-59% -$14.8M 0.73% 20
2024
Q3 		$22.7M Sell
666,308
-191,596
-22% -$5.39M 1.51% 16
2024
Q2 		$18.6M Hold
857,904
– – 1.42% 17
2024
Q1 		$19M Buy
+857,904
New +$20.9M 1.41% 20

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Casdin Capital's VCYT Position: Q1 2026 in Review

Casdin Capital held its Veracyte (VCYT) position steady in Q1 2026 at 276,308 shares worth $8.9M. The position accounts for 0.67% of the portfolio, ranked #26.

Casdin Capital first reported a position in VCYT in Q1 2024 and has held it in 9 quarters since. The position peaked at $22.7M in Q3 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Casdin Capital held 276,308 shares of Veracyte worth $8.9M as of Q1 2026.
  • Casdin Capital left its Veracyte share count unchanged in Q1 2026.
  • Veracyte made up 0.67% of Casdin Capital's portfolio in Q1 2026, its #26 holding.
  • Casdin Capital first reported a position in Veracyte in Q1 2024 and has held it in 9 quarters since.
  • Casdin Capital's Veracyte position peaked at $22.7M in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Casdin Capital's 13F filing for Q1 2026, filed 15 May 2026.